Dr. Martens plc (LON:DOCS – Get Free Report) insider Giles Wilson purchased 207 shares of the firm’s stock in a transaction on Tuesday, February 11th. The stock was bought at an average price of GBX 73 ($0.91) per share, for a total transaction of £151.11 ($188.16).
Giles Wilson also recently made the following trade(s):
- On Monday, January 13th, Giles Wilson bought 222 shares of Dr. Martens stock. The stock was purchased at an average price of GBX 68 ($0.85) per share, for a total transaction of £150.96 ($187.97).
Dr. Martens Trading Up 1.0 %
Shares of Dr. Martens stock traded up GBX 0.71 ($0.01) during trading hours on Wednesday, reaching GBX 72.01 ($0.90). The stock had a trading volume of 929,960 shares, compared to its average volume of 1,796,671. The firm has a market capitalization of £692.53 million, a price-to-earnings ratio of 1,028.71, a P/E/G ratio of 6.40 and a beta of 0.11. Dr. Martens plc has a 1 year low of GBX 49.32 ($0.61) and a 1 year high of GBX 100 ($1.25). The company has a current ratio of 2.85, a quick ratio of 1.13 and a debt-to-equity ratio of 129.55. The firm has a 50 day simple moving average of GBX 72.27 and a two-hundred day simple moving average of GBX 65.54.
Dr. Martens Cuts Dividend
The business also recently declared a dividend, which will be paid on Tuesday, April 8th. Investors of record on Thursday, March 6th will be issued a GBX 0.85 ($0.01) dividend. The ex-dividend date of this dividend is Thursday, March 6th. This represents a yield of 1.47%. Dr. Martens’s dividend payout ratio is currently 4,285.71%.
Dr. Martens Company Profile
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Featured Stories
- Five stocks we like better than Dr. Martens
- Quiet Period Expirations Explained
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- How to Invest in Biotech Stocks
- Inflation Persists, But So Do Stock Opportunities: Rally On
- How to Capture the Benefits of Dividend Increases
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.